An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians
Austin Granatowicz, Caroline I. Piatek, Elizabeth Moschiano, Ihab El-Hemaidi, Joel D. Armitage, Mojtaba Akhtari
Korean J Fam Med. 2015;36(5):197-202.   Published online 2015 Sep 18     DOI: https://doi.org/10.4082/kjfm.2015.36.5.197
Citations to this article as recorded by Crossref logo
Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia
Luma Al-Ali, Raad J. Al-Ani, Maysaa M. Saleh, Alaa M. Hammad, Duaa A. Abuarqoub, Bashaer Abu-Irmaileh, Abdallah Y. Naser, Manal M. Najdawi, Manal M. Abbas, Jamal Alyoussef Alkrad
Saudi Pharmaceutical Journal.2024; 32(2): 101931.     CrossRef
Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
Rachel L. Mynott, Ali Habib, Oliver G. Best, Craig T. Wallington-Gates
International Journal of Molecular Sciences.2023; 24(8): 7661.     CrossRef
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Sunitha Shyam Sunder, Umesh C. Sharma, Saraswati Pokharel
Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
Pharmacological and therapeutic potentials of cordycepin in hematological malignancies
Zahra Taghinejad, Tohid Kazemi, Manouchehr Fadaee, Majid farshdousti hagh, Saeed Solali
Biochemical and Biophysical Research Communications.2023; 678: 135.     CrossRef
A Case of JAK2V617F-Negative Myeloproliferative Neoplasm in a Young Female Presenting With Extreme Thrombocytosis
Kelash Kumar, Assile Koubeissy, Arichanah Pulenthiran, Amrat Kumar, Amit Gulati, Brian Wolf, Stephen Peeke
Cureus.2023;[Epub]     CrossRef
CD99 in malignant hematopoiesis
Atham Ali, Vijaya Pooja Vaikari, Houda Alachkar
Experimental Hematology.2022; 106: 40.     CrossRef
The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate
Shinta Oktya Wardhani, Hani Susianti, Puji Rahayu, Yuyun Prabowowati Yueniwati, Jonny Karunia Fajar
F1000Research.2022; 10: 1003.     CrossRef
Asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL. (+) without splenomegaly: A case report
W Rajabto, YK Angkasa
Nigerian Journal of Clinical Practice.2022; 25(3): 373.     CrossRef
Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Dan Ran Castillo, Daniel Park, Akhil Mehta, Simmer Kaur, Anthony Nguyen, Mojtaba Akhtari
Hematology Reports.2022; 14(1): 45.     CrossRef
The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate
Shinta Oktya Wardhani, Hani Susianti, Puji Rahayu, Yuyun Prabowowati Yueniwati, Jonny Karunia Fajar
F1000Research.2022; 10: 1003.     CrossRef
Chronic myeloid leukaemia presenting as acute pulmonary thromboembolism
Mallikarjuna Shetty, Rami Reddy Gari Purushotham Reddy, Srigadha Vivek Kumar, Dasarapu Sravan Kumar
Journal of Clinical and Scientific Research.2022; 11(3): 181.     CrossRef
Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
Omar Prado-Carrillo, Abner Arenas-Ramírez, Monserrat Llaguno-Munive, Rafael Jurado, Jazmin Pérez-Rojas, Eduardo Cervera-Ceballos, Patricia Garcia-Lopez
International Journal of Molecular Sciences.2022; 23(14): 7715.     CrossRef
Spontaneous tumor lysis syndrome in a patient with accelerated phase chronic myeloid leukemia treated successfully with rasburicase
Abdulrahman F. Al-Mashdali, Mohamed A. Yassin
Medicine: Case Reports and Study Protocols.2022; 3(7): e0244.     CrossRef
Imatinib and Patient-Related Outcomes in Chronic Myeloid Leukemia: A Single Centric Experience
Avinash Kumar Singh, Mohammad Azharuddin, Narendra Agrawal, Dinesh Bhurani, Rayaz Ahmed, Manju Sharma
SN Comprehensive Clinical Medicine.2022;[Epub]     CrossRef
A Systematic Literature Review of the Economic Evaluations of Treatments for Patients with Chronic Myeloid Leukemia
Rumjhum Agrawal, Joao Vieira, Jacqueline Ryan, Harish Negi, Tanvi Rajput, Regina Corbin, Ricardo Viana
PharmacoEconomics.2022; 40(12): 1159.     CrossRef
A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia
Honglan Qian, Dongxu Gang, Xiaoyu He, Songfu Jiang
Frontiers in Oncology.2022;[Epub]     CrossRef
Chronic myelogenous leukemia presenting with Morel Lavallée lesion: A case report of a rare presentation
Sara S. I. Mohamed, Hana Mahmoud Qasim, Ahmed Mahfouz, Maab A. Osman, Ashraf O. E. Ahmed, Safa H. Al‐Azewi, Mohamad A. Yassin, Shehab Fareed
Clinical Case Reports.2022;[Epub]     CrossRef
Leukocytosis and Tobacco Use: An Observational Study of Asymptomatic Leukocytosis
Caleb J. Smith, Lindsey Ann Kluck, Gordon J. Ruan, Aneel A. Ashrani, Ariela L. Marshall, Rajiv K. Pruthi, Mithun Vinod Shah, Alexandra Wolanskyj-Spinner, Naseema Gangat, Mark R. Litzow, William J. Hogan, Meera Sridharan, Ronald S. Go
The American Journal of Medicine.2021; 134(1): e31.     CrossRef
Association of tuberculosis in patients with chronic myeloid leukemia: a treatment proposal based on literature review
Phool Iqbal, Ashraf Soliman, Vincenzo De Sanctis, Mohamed A. Yassin
Expert Review of Hematology.2021; 14(2): 211.     CrossRef
Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review
Mariana Miranda Sampaio, Maria Luísa Cordeiro Santos, Hanna Santos Marques, Vinícius Lima de Souza Gonçalves, Glauber Rocha Lima Araújo, Luana Weber Lopes, Jonathan Santos Apolonio, Camilo Santana Silva, Luana Kauany de Sá Santos, Beatriz Rocha Cuzzuol, Q
World Journal of Clinical Oncology.2021; 12(2): 69.     CrossRef
Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis
Ahmad Adel, Dina Abushanab, Anas Hamad, Mohammad Abdulla, Mohamed Izham, Mohamed Yassin
Cancer Control.2021; 28: 107327482110017.     CrossRef
The Levels of FoxO3a Predict the Failure of Imatinib Mesylate Therapy among Chronic Myeloid Leukemia Patients
Shinta Oktya Wardhani, Hani Susanti, Puji Rahayu, Yuyun Yueniwati, Jonny Fajar
Open Access Macedonian Journal of Medical Sciences.2021; 9(B): 255.     CrossRef
44-Year-Old Man With Fatigue, Weight Loss, and Leukocytosis
Caleb J. Smith, Glenn Stewart, Kebede Begna
Mayo Clinic Proceedings.2021; 96(7): 1944.     CrossRef
Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?
Hilbeen Hisham Saifullah, Claire Marie Lucas
Cancers.2021; 13(16): 4175.     CrossRef
Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Suvankar Banerjee, Sk. Abdul Amin, Tarun Jha
Current Chemical Biology.2021; 15(1): 19.     CrossRef
The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate
Shinta Oktya Wardhani, Hani Susianti, Puji Rahayu, Yuyun Prabowowati Yueniwati, Jonny Karunia Fajar
F1000Research.2021; 10: 1003.     CrossRef
High STAT5A Expression is Associated with Major Molecular Response Achievement Failure of Chronic Phase Chronic Myeloid Leukemia Patients Receiving Hydroxyurea before Imatinib: A Cross-sectional Study
Ikhwan Rinaldi, Anastasia Putri, Melva Louisa, Sukamto Koesnoe
Open Access Macedonian Journal of Medical Sciences.2021; 9(B): 1160.     CrossRef
DNA‐binding activity and cytotoxic and cell‐cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation
Fariba Khosravifar, Gholamreza Dehghan, Seyed Kazem Bidoki, Majid Mahdavi
Luminescence.2020; 35(1): 98.     CrossRef
MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, Parviz Vahedi, Afshin Derakhshani, Oronzo Brunetti, Amir Baghbanzadeh, Behzad Mansoori, Nicola Silvestris, Behzad Baradaran
International Journal of Molecular Sciences.2020; 21(7): 2578.     CrossRef
Clinical Features and Outcomes of Patients With Chronic Myeloid Leukemia Presenting With Isolated Thrombocytosis: A Systematic Review and a Case From Our Institution
Dawood Findakly, Waqas Arslan
Cureus.2020;[Epub]     CrossRef
Cardiovascular Events throughout the Disease Course in Chronic Myeloid Leukaemia Patients Treated with Tyrosine Kinase Inhibitors—A Single-Centre Retrospective Study
Andreea Varga, Ioan Tilea, Dorina Nastasia Petra, Mariana-Cornelia Tilinca, Mirela Liana Gliga, Smaranda Demian
Journal of Clinical Medicine.2020; 9(10): 3269.     CrossRef
The Association Between the Level of Leukemic Stem Cells and Treatment Response Among Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate
Shinta Oktya Wardhani, Hani Susianti, Puji Rahayu, Yuyun Yueniwati
Clinical Cancer Drugs.2020; 7(2): 119.     CrossRef
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib
David J Hermel, Victor Chiu, Melody H Hermel, Anil Tulpule, Mojtaba Akhtari
Journal of Oncology Pharmacy Practice.2019; 25(3): 699.     CrossRef
A Synergistic Combination Against Chronic Myeloid Leukemia: An Intra-molecular Mechanism of Communication in BCR–ABL1 Resistance
Ahmed A. El Rashedy, Patrick Appiah-Kubi, Mahmoud E. S. Soliman
The Protein Journal.2019; 38(2): 142.     CrossRef
The Perplexity of Synergistic Duality: Inter-molecular Mechanisms of Communication in BCR-ABL1
Ahmed A. Elrashedy, Pritika Ramharack, Mahmoud E.S. Soliman
Anti-Cancer Agents in Medicinal Chemistry.2019; 19(13): 1642.     CrossRef
Is Myc an Important Biomarker? Myc Expression in Immune Disorders and Cancer
Shivtia Trop-Steinberg, Yehudit Azar
The American Journal of the Medical Sciences.2018; 355(1): 67.     CrossRef
Dysregulated expression of SKP2 and its role in hematological malignancies
Michal Kulinski, Iman W. Achkar, Mohammad Haris, Said Dermime, Ramzi M. Mohammad, Shahab Uddin
Leukemia & Lymphoma.2018; 59(5): 1051.     CrossRef
Leukemia biomarker detection by using photoconductive response of CNT electrode: Analysis of sensing mechanism based on charge transfer induced Fermi level fluctuation
Payal Gulati, Prabhjot Kaur, M.V. Rajam, Tapasya Srivastava, Md. Azahar Ali, Prabhash Mishra, S.S. Islam
Sensors and Actuators B: Chemical.2018; 270: 45.     CrossRef
Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review
Jie Fu, Yuchen Liu, Houwen Lin, Bin Wu
Clinical Drug Investigation.2018; 38(12): 1167.     CrossRef
Potential Leukemic Cells Engraftment After Hematopoietic Stem Cell Transplantation From Unrelated Donors With Undiagnosed Chronic Leukemia
M.P. Kawa, B. Baumert, Z. Litwińska, M. Gniot, E. Pius-Sadowska, D. Rogińska, K. Lewandowski, B. Zdziarska, B. Machaliński
Transplantation Proceedings.2018; 50(10): 3789.     CrossRef
AP-1 Expression and its Clinical Relevance in Immune Disorders and Cancer
Shivtia Trop-Steinberg, Yehudit Azar
The American Journal of the Medical Sciences.2017; 353(5): 474.     CrossRef
Chronic myeloid leukaemia: A guide for practice nurses
Margaret Ann Perry
Practice Nursing.2017; 28(10): 419.     CrossRef
Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting
Blaise Felix Faye, Nata Dieng, Moussa Seck, Macoura Gadji, Youssou Bamar Gueye, Diariatou Sy, Sokhna Aissatou Toure, Abibatou Sall, Awa Oumar Toure, Tandakha Ndiaye Dieye, Saliou Diop
Annals of Hematology.2016; 95(10): 1603.     CrossRef